1. Home
  2. DNA vs SLRC Comparison

DNA vs SLRC Comparison

Compare DNA & SLRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

BUY

Current Price

$11.22

Market Cap

835.7M

Sector

Health Care

ML Signal

BUY

Logo SLR Investment Corp.

SLRC

SLR Investment Corp.

BUY

Current Price

$11.53

Market Cap

691.2M

Sector

Finance

ML Signal

BUY

Company Overview

Basic Information
Metric
DNA
SLRC
Founded
2008
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
835.7M
691.2M
IPO Year
2020
2007

Fundamental Metrics

Financial Performance
Metric
DNA
SLRC
Price
$11.22
$11.53
Analyst Decision
Sell
Buy
Analyst Count
3
8
Target Price
$7.00
★ $14.88
AVG Volume (30 Days)
★ 3.0M
369.2K
Earning Date
11-05-2026
11-03-2026
Dividend Yield
N/A
★ 10.78%
EPS Growth
★ 46.49
N/A
EPS
N/A
★ 0.47
Revenue
★ $170,155,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.37
$0.90
P/E Ratio
★ N/A
$24.47
Revenue Growth
N/A
★ N/A
52 Week Low
$5.37
$11.23
52 Week High
$18.22
$16.36

Technical Indicators

Market Signals
Indicator
DNA
SLRC
Relative Strength Index (RSI) 56.80 34.17
Support Level $6.86 N/A
Resistance Level N/A $13.33
Average True Range (ATR) 1.63 0.18
MACD 0.20 -0.01
Stochastic Oscillator 35.01 29.27

Price Performance

Historical Comparison
DNA
SLRC

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

About SLRC SLR Investment Corp.

SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. The company's investment objective is to generate both current income and capital appreciation through debt and equity investments. The company invests principally in leveraged middle-market companies in the form of senior secured loans, financing leases, and to a lesser extent, unsecured loans and equity securities.

Share on Social Networks: